Form 8-K - Current report:
SEC Accession No. 0001437749-23-029404
Filing Date
2023-10-30
Accepted
2023-10-30 16:13:31
Documents
14
Period of Report
2023-10-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tmbr20231028_8k.htm   iXBRL 8-K 44610
2 EXHIBIT 10.1 ex_587351.htm EX-10.1 38610
  Complete submission text file 0001437749-23-029404.txt   228614

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tmbr-20231030.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmbr-20231030_def.xml EX-101.DEF 11425
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmbr-20231030_lab.xml EX-101.LAB 15311
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmbr-20231030_pre.xml EX-101.PRE 11585
8 EXTRACTED XBRL INSTANCE DOCUMENT tmbr20231028_8k_htm.xml XML 2561
Mailing Address 3 MOUNTAINVIEW ROAD, SUITE 100 WARREN NJ 07059
Business Address 3 MOUNTAINVIEW ROAD, SUITE 100 WARREN NJ 07059 (917) 697-3130
Timber Pharmaceuticals, Inc. (Filer) CIK: 0001504167 (see all company filings)

EIN.: 593843182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 231360363
SIC: 2834 Pharmaceutical Preparations